{"id":"https://openalex.org/W4389136367","doi":"https://doi.org/10.1513/annalsats.202308-735rl","title":"Assessing Safety of Discontinuing Hypertonic Saline in Those with Lower Forced Expiratory Volume in 1 Second after Elexacaftor/Tezacaftor/Ivacaftor","display_name":"Assessing Safety of Discontinuing Hypertonic Saline in Those with Lower Forced Expiratory Volume in 1 Second after Elexacaftor/Tezacaftor/Ivacaftor","publication_year":2023,"publication_date":"2023-11-29","ids":{"openalex":"https://openalex.org/W4389136367","doi":"https://doi.org/10.1513/annalsats.202308-735rl","pmid":"https://pubmed.ncbi.nlm.nih.gov/38019099","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12042950"},"language":"en","primary_location":{"id":"doi:10.1513/annalsats.202308-735rl","doi":"https://doi.org/10.1513/annalsats.202308-735rl","is_oa":false,"landing_page_url":"https://doi.org/10.1513/annalsats.202308-735rl","pdf_url":null,"source":{"id":"https://openalex.org/S4210233309","display_name":"Annals of the American Thoracic Society","issn_l":"2325-6621","issn":["2325-6621","2329-6933"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316311","host_organization_name":"American Thoracic Society","host_organization_lineage":["https://openalex.org/P4310316311"],"host_organization_lineage_names":["American Thoracic Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the American Thoracic Society","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12042950/pdf/annalsats.202308-735rl.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015765237","display_name":"David P. Nichols","orcid":"https://orcid.org/0000-0001-8611-7960","observed_orcids":["https://orcid.org/0000-0001-8611-7960"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I2800138454","display_name":"Cystic Fibrosis Foundation","ror":"https://ror.org/00ax59295","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2800138454"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David Nichols","raw_affiliation_strings":["University of Washington Seattle, Washington","Cystic Fibrosis Foundation, 71458, Bethesda, Maryland, United States;; University of Washington School of Medicine, 12353, Pediatrics, Seattle, Washington, United States"],"raw_orcid":"https://orcid.org/0000-0001-8611-7960","affiliations":[{"raw_affiliation_string":"University of Washington Seattle, Washington","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Cystic Fibrosis Foundation, 71458, Bethesda, Maryland, United States;; University of Washington School of Medicine, 12353, Pediatrics, Seattle, Washington, United States","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I2800138454"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027118818","display_name":"Alex H. Gifford","orcid":"https://orcid.org/0000-0002-6404-3793","observed_orcids":["https://orcid.org/0000-0002-6404-3793"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Gifford","raw_affiliation_strings":["Case Western Reserve University Cleveland, Ohio","Case Western Reserve University, 2546, Cleveland, Ohio, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Western Reserve University Cleveland, Ohio","institution_ids":["https://openalex.org/I58956616"]},{"raw_affiliation_string":"Case Western Reserve University, 2546, Cleveland, Ohio, United States","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043288625","display_name":"Renee Russell","orcid":"https://orcid.org/0000-0002-0867-8516","observed_orcids":["https://orcid.org/0000-0002-0867-8516"]},"institutions":[{"id":"https://openalex.org/I1295499534","display_name":"Seattle Children's Hospital","ror":"https://ror.org/01njes783","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295499534"]},{"id":"https://openalex.org/I4405262941","display_name":"Seattle Children's Research Institute","ror":"https://ror.org/00cz0md82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295499534","https://openalex.org/I4405262941"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Renee Russell","raw_affiliation_strings":["Seattle Children\u2019s Research Institute Seattle, Washington","Seattle Children's Hospital, 7274, Seattle, Washington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Children\u2019s Research Institute Seattle, Washington","institution_ids":["https://openalex.org/I4405262941"]},{"raw_affiliation_string":"Seattle Children's Hospital, 7274, Seattle, Washington, United States","institution_ids":["https://openalex.org/I1295499534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060299759","display_name":"Katherine Odem\u2010Davis","orcid":"https://orcid.org/0000-0002-9779-2571","observed_orcids":["https://orcid.org/0000-0002-9779-2571"]},"institutions":[{"id":"https://openalex.org/I4405262941","display_name":"Seattle Children's Research Institute","ror":"https://ror.org/00cz0md82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295499534","https://openalex.org/I4405262941"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine Odem-Davis","raw_affiliation_strings":["Seattle Children\u2019s Research Institute Seattle, Washington","Seattle Children's Research Institute, Seattle, Washington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Children\u2019s Research Institute Seattle, Washington","institution_ids":["https://openalex.org/I4405262941"]},{"raw_affiliation_string":"Seattle Children's Research Institute, Seattle, Washington, United States","institution_ids":["https://openalex.org/I4405262941"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Julia Young","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800138454","display_name":"Cystic Fibrosis Foundation","ror":"https://ror.org/00ax59295","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2800138454"]},{"id":"https://openalex.org/I4405262941","display_name":"Seattle Children's Research Institute","ror":"https://ror.org/00cz0md82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295499534","https://openalex.org/I4405262941"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julia Young","raw_affiliation_strings":["Seattle Children\u2019s Research Institute Seattle, Washington","Seattle Children's Research Institute, 145793, Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle, Washington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Children\u2019s Research Institute Seattle, Washington","institution_ids":["https://openalex.org/I4405262941"]},{"raw_affiliation_string":"Seattle Children's Research Institute, 145793, Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle, Washington, United States","institution_ids":["https://openalex.org/I2800138454","https://openalex.org/I4405262941"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057469943","display_name":"Rodolfo Amaro-Galvez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I90436673","display_name":"The University of Texas Health Science Center at Tyler","ror":"https://ror.org/01sps7q28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I90436673"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rodolfo Amaro-Galvez","raw_affiliation_strings":["University of Texas Health Science Center Tyler, Texas","The University of Texas Health Science Center at Tyler, 12341, Tyler, Texas, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Health Science Center Tyler, Texas","institution_ids":["https://openalex.org/I90436673"]},{"raw_affiliation_string":"The University of Texas Health Science Center at Tyler, 12341, Tyler, Texas, United States","institution_ids":["https://openalex.org/I90436673"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086716042","display_name":"Joanne L. Billings","orcid":"https://orcid.org/0000-0002-9513-4057","observed_orcids":["https://orcid.org/0000-0002-9513-4057"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joanne Billings","raw_affiliation_strings":["University of Minnesota Minneapolis, Minnesota","University of Minnesota, Pulmonary, Allergy, Critical Care and Sleep Medicine, Minneapolis, Minnesota, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota Minneapolis, Minnesota","institution_ids":["https://openalex.org/I130238516"]},{"raw_affiliation_string":"University of Minnesota, Pulmonary, Allergy, Critical Care and Sleep Medicine, Minneapolis, Minnesota, United States","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051116781","display_name":"Zubin Mukadam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zubin Mukadam","raw_affiliation_strings":["Wayne State University Detroit, Michigan","Wayne State University, 2954, Detroit, Michigan, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wayne State University Detroit, Michigan","institution_ids":["https://openalex.org/I185443292"]},{"raw_affiliation_string":"Wayne State University, 2954, Detroit, Michigan, United States","institution_ids":["https://openalex.org/I185443292"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062599923","display_name":"Nicole Mayer-Hamblett","orcid":"https://orcid.org/0000-0001-5538-9197","observed_orcids":["https://orcid.org/0000-0001-5538-9197"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4405262941","display_name":"Seattle Children's Research Institute","ror":"https://ror.org/00cz0md82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295499534","https://openalex.org/I4405262941"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole Mayer-Hamblett","raw_affiliation_strings":["TDN Coordinating Center Seattle Children\u2019s Research Institute Seattle, Washington","University of Washington Seattle, Washington","University of Washington, Pediatrics, Seattle, Washington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TDN Coordinating Center Seattle Children\u2019s Research Institute Seattle, Washington","institution_ids":["https://openalex.org/I4405262941"]},{"raw_affiliation_string":"University of Washington Seattle, Washington","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"University of Washington, Pediatrics, Seattle, Washington, United States","institution_ids":["https://openalex.org/I201448701"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5015765237"],"corresponding_institution_ids":["https://openalex.org/I201448701","https://openalex.org/I2800138454"],"apc_list":null,"apc_paid":null,"fwci":0.7337,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.72384124,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":97},"biblio":{"volume":"21","issue":"2","first_page":"360","last_page":"362"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cystic-fibrosis","display_name":"cystic fibrosis","score":0.9700000286102295},{"id":"https://openalex.org/keywords/elexacaftor-tezacaftor-ivacaftor","display_name":"elexacaftor/tezacaftor/ivacaftor","score":0.9729999899864197},{"id":"https://openalex.org/keywords/hypertonic-saline","display_name":"hypertonic saline","score":0.8989999890327454},{"id":"https://openalex.org/keywords/dornase-alfa","display_name":"dornase alfa","score":0.8730000257492065},{"id":"https://openalex.org/keywords/cftr-modulator-therapy","display_name":"CFTR modulator therapy","score":0.8140000104904175},{"id":"https://openalex.org/keywords/treatment-simplification","display_name":"treatment simplification","score":0.6259999871253967},{"id":"https://openalex.org/keywords/fev1","display_name":"FEV1","score":0.8920000195503235},{"id":"https://openalex.org/keywords/lung-function","display_name":"lung function","score":0.8220000267028809},{"id":"https://openalex.org/keywords/respiratory-symptoms","display_name":"respiratory symptoms","score":0.5109999775886536},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6940000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9224770069122314},{"id":"https://openalex.org/C3017567848","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Hypertonic saline","level":2,"score":0.8537896871566772},{"id":"https://openalex.org/C2776502428","wikidata":"https://www.wikidata.org/wiki/Q6095693","display_name":"Ivacaftor","level":4,"score":0.8465020060539246},{"id":"https://openalex.org/C20556612","wikidata":"https://www.wikidata.org/wiki/Q4469374","display_name":"Volume (thermodynamics)","level":2,"score":0.4404892325401306},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.4185383915901184},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3190876245498657},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23988595604896545},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C2778428886","wikidata":"https://www.wikidata.org/wiki/Q420470","display_name":"Cystic fibrosis transmembrane conductance regulator","level":3,"score":0.0},{"id":"https://openalex.org/C2776938444","wikidata":"https://www.wikidata.org/wiki/Q178194","display_name":"Cystic fibrosis","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000627","descriptor_name":"Aminophenols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003550","descriptor_name":"Cystic Fibrosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005541","descriptor_name":"Forced Expiratory Volume","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019005","descriptor_name":"Cystic Fibrosis Transmembrane Conductance Regulator","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D052117","descriptor_name":"Benzodioxoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1513/annalsats.202308-735rl","doi":"https://doi.org/10.1513/annalsats.202308-735rl","is_oa":false,"landing_page_url":"https://doi.org/10.1513/annalsats.202308-735rl","pdf_url":null,"source":{"id":"https://openalex.org/S4210233309","display_name":"Annals of the American Thoracic Society","issn_l":"2325-6621","issn":["2325-6621","2329-6933"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316311","host_organization_name":"American Thoracic Society","host_organization_lineage":["https://openalex.org/P4310316311"],"host_organization_lineage_names":["American Thoracic Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the American Thoracic Society","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12042950","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12042950","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12042950/pdf/annalsats.202308-735rl.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ann Am Thorac Soc","raw_type":"Text"},{"id":"pmid:38019099","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38019099","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the American Thoracic Society","raw_type":"Letter"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:12042950","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12042950","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12042950/pdf/annalsats.202308-735rl.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ann Am Thorac Soc","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.44999998807907104,"display_name":"Climate action","id":"https://metadata.un.org/sdg/13"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000868740","display_name":"Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator Era","funder_award_id":"P30DK089507","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G9000897255","display_name":"Institute of Translational Health Sciences","funder_award_id":"UL1TR002319","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320306168","display_name":"Cystic Fibrosis Foundation","ror":"https://ror.org/00ax59295"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4389136367.pdf","grobid_xml":"https://content.openalex.org/works/W4389136367.grobid-xml"},"referenced_works_count":5,"referenced_works":["https://openalex.org/W2060041446","https://openalex.org/W2151174404","https://openalex.org/W2991288772","https://openalex.org/W3125432050","https://openalex.org/W4308349064"],"related_works":["https://openalex.org/W4400918136","https://openalex.org/W4379981494","https://openalex.org/W4308349064","https://openalex.org/W4380301153","https://openalex.org/W4387746226","https://openalex.org/W4391788073","https://openalex.org/W4380354236","https://openalex.org/W4387746507","https://openalex.org/W4386090587","https://openalex.org/W7204011778"],"abstract_inverted_index":{"Assessing":[0],"Safety":[1],"of":[2,23,77,231,251],"Discontinuing":[3],"Hypertonic":[4],"Saline":[5],"in":[6,13,87,89,108,113,152,156,163,208,213,264,272],"Those":[7],"with":[8,37,74,168,173,195,219,246],"Lower":[9],"Forced":[10],"Expiratory":[11],"Volume":[12],"1":[14,114,117,158,199,205,250,266],"Second":[15],"after":[16,186,226],"Elexacaftor/Tezacaftor/IvacaftorTo":[17],"the":[18,20,68,72,75,90,146,153,239],"Editor:With":[19],"widespread":[21],"introduction":[22],"highly":[24],"effective":[25],"cystic":[26],"fibrosis":[27],"(CF)":[28],"transmembrane":[29],"conductance":[30],"regulator":[31],"modulator":[32],"therapy":[33],"(HEMT),":[34],"many":[35],"people":[36,194],"CF":[38],"(pwCF)":[39],"and":[40,171,225,229,275,279],"care":[41],"providers":[42],"want":[43],"to":[44,61,181,193,217,253,281],"know":[45],"whether":[46],"daily":[47,78,83,184],"therapies":[48,185],"can":[49],"be":[50],"used":[51],"less":[52],"often":[53],"without":[54],"sacrificing":[55],"health":[56],"improvements":[57],"that":[58,131],"are":[59],"attributable":[60],"HEMT":[62],"(1).In":[63],"parallel,":[64],"randomized":[65,178,242],"controlled":[66,179],"trials,":[67],"SIMPLIFY":[69,240],"study":[70],"compared":[71],"continuation":[73],"discontinuation":[76,170],"hypertonic":[79],"saline":[80],"(HS)":[81],"or":[82,124,133,136,255],"dornase":[84],"alfa":[85],"(DA)":[86],"pwCF":[88,243],"United":[91],"States":[92],"using":[93],"elexacaftor/tezacaftor/ivacaftor":[94],"(ETI)":[95],"for":[96,127,138,145],"at":[97],"least":[98],"3":[99],"months":[100],"(2).These":[101],"trials":[102,165,210],"demonstrated":[103],"no":[104],"clinically":[105],"meaningful":[106],"differences":[107],"percent-predicted":[109],"forced":[110],"expiratory":[111],"volume":[112],"second":[115],"(ppFEV":[116],"),":[118],"lung":[119,221,273],"clearance":[120],"index,":[121],"symptom":[122,277],"reporting,":[123],"acute":[125],"need":[126],"antibiotics":[128],"between":[129],"groups":[130],"continued":[132],"discontinued":[134],"HS":[135,169],"DA":[137,174],"6":[139],"weeks":[140],"(3).The":[141,211],"tested":[142],"noninferiority":[143],"margin":[144],"primary":[147],"outcome":[148],"was":[149,166,190,206,223],"23%":[150],"difference":[151,161],"6-week":[154],"change":[155,263],"ppFEV":[157,198,204,249,265],".The":[159],"absolute":[160],"measured":[162],"these":[164,215],"20.32%":[167],"0.35%":[172],"discontinuation.In":[175],"this":[176],"first":[177],"trial":[180,241],"consider":[182],"simplifying":[183],"starting":[187],"ETI,":[188],"enrollment":[189],"cautiously":[191],"limited":[192],"a":[196,234,247],"baseline":[197,202,248],">60%.The":[200],"observed":[201],"mean":[203],"97%":[207],"both":[209],"difficulty":[212],"generalizing":[214],"results":[216],"those":[218],"lower":[220],"function":[222,274],"recognized,":[224],"interim":[227],"review":[228],"approval":[230],"safety":[232,260],"data,":[233],"preplanned,":[235],"independent":[236],"substudy":[237],"within":[238],"on":[244],"ETI":[245],"40-59%":[252],"continue":[254],"discontinue":[256],"HS.Analyses":[257],"included":[258],"descriptive":[259],"summaries":[261],"comparing":[262],",":[267],"collected":[268],"adverse":[269],"events,":[270],"changes":[271],"respiratory":[276],"scores,":[278],"adherence":[280],"treatment":[282],"assignment.":[283],"Methods":[284]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-11-30T00:00:00"}